154 related articles for article (PubMed ID: 18291361)
1. Resveratrol attenuates thromboxane A2 receptor agonist-induced platelet activation by reducing phospholipase C activity.
Yang YM; Chen JZ; Wang XX; Wang SJ; Hu H; Wang HQ
Eur J Pharmacol; 2008 Mar; 583(1):148-55. PubMed ID: 18291361
[TBL] [Abstract][Full Text] [Related]
2. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
Lockhart LK; McNicol A
J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of resveratrol on platelet activation induced by thromboxane a(2) receptor agonist in human platelets.
Yang Y; Wang X; Zhang L; An H; Zao Z
Am J Chin Med; 2011; 39(1):145-59. PubMed ID: 21213405
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.
Bleasdale JE; Thakur NR; Gremban RS; Bundy GL; Fitzpatrick FA; Smith RJ; Bunting S
J Pharmacol Exp Ther; 1990 Nov; 255(2):756-68. PubMed ID: 2147038
[TBL] [Abstract][Full Text] [Related]
5. Evidence for separate effects of U73122 on phospholipase C and calcium channels in human platelets.
Pulcinelli FM; Gresele P; Bonuglia M; Gazzaniga PP
Biochem Pharmacol; 1998 Dec; 56(11):1481-4. PubMed ID: 9827580
[TBL] [Abstract][Full Text] [Related]
6. In vivo activity of a phospholipase C inhibitor, 1-(6-((17beta-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (U73122), in acute and chronic inflammatory reactions.
Hou C; Kirchner T; Singer M; Matheis M; Argentieri D; Cavender D
J Pharmacol Exp Ther; 2004 May; 309(2):697-704. PubMed ID: 14730005
[TBL] [Abstract][Full Text] [Related]
7. The aminosteroid phospholipase C antagonist U-73122 (1-[6-[[17-beta-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione) potently inhibits human 5-lipoxygenase in vivo and in vitro.
Feisst C; Albert D; Steinhilber D; Werz O
Mol Pharmacol; 2005 May; 67(5):1751-7. PubMed ID: 15684042
[TBL] [Abstract][Full Text] [Related]
8. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
[TBL] [Abstract][Full Text] [Related]
9. Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness.
Smith RJ; Sam LM; Justen JM; Bundy GL; Bala GA; Bleasdale JE
J Pharmacol Exp Ther; 1990 May; 253(2):688-97. PubMed ID: 2338654
[TBL] [Abstract][Full Text] [Related]
10. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase.
Lee JJ; Yu JY; Lee JH; Zhang WY; Kim TJ; Myung CS; Yun YP
Arch Pharm Res; 2010 Mar; 33(3):387-94. PubMed ID: 20361303
[TBL] [Abstract][Full Text] [Related]
11. KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism.
Lévy-Toledano S; Grelac F; Caen JP; Maclouf J
Thromb Haemost; 1995 May; 73(5):857-61. PubMed ID: 7482416
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol attenuates adenosine diphosphate-induced platelet activation by reducing protein kinase C activity.
Yang YM; Wang XX; Chen JZ; Wang SJ; Hu H; Wang HQ
Am J Chin Med; 2008; 36(3):603-13. PubMed ID: 18543392
[TBL] [Abstract][Full Text] [Related]
13. Functional role of p38 mitogen activated protein kinase in platelet activation induced by a thromboxane A2 analogue and by 8-iso-prostaglandin F2alpha.
Minuz P; Gaino S; Zuliani V; Tommasoli RM; Benati D; Ortolani R; Zancanaro C; Berton G; Santonastaso CL
Thromb Haemost; 2002 May; 87(5):888-98. PubMed ID: 12038794
[TBL] [Abstract][Full Text] [Related]
14. Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human platelets.
Minuz P; Fumagalli L; Gaino S; Tommasoli RM; Degan M; Cavallini C; Lecchi A; Cattaneo M; Lechi Santonastaso C; Berton G
Biochem J; 2006 Nov; 400(1):127-34. PubMed ID: 16859489
[TBL] [Abstract][Full Text] [Related]
15. 1, 6-di-O-caffeoyl-β-D-glucopyranoside, a natural compound from Callicarpa nudiflora Hook impairs P2Y
Fu J; Zhu X; Wang W; Lu H; Zhang Z; Liu T; Xu H; Fu H; Ma S; Luo Y
Phytomedicine; 2017 Dec; 36():273-282. PubMed ID: 29157825
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of resveratrol-induced platelet apoptosis.
Lin KH; Hsiao G; Shih CM; Chou DS; Sheu JR
Cardiovasc Res; 2009 Aug; 83(3):575-85. PubMed ID: 19423619
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP.
Shen MY; Hsiao G; Liu CL; Fong TH; Lin KH; Chou DS; Sheu JR
Br J Haematol; 2007 Nov; 139(3):475-85. PubMed ID: 17868048
[TBL] [Abstract][Full Text] [Related]
18. Timosaponin AIII induces antiplatelet and antithrombotic activity via Gq-mediated signaling by the thromboxane A2 receptor.
Cong Y; Wang L; Peng R; Zhao Y; Bai F; Yang C; Liu X; Wang D; Ma B; Cong Y
Sci Rep; 2016 Dec; 6():38757. PubMed ID: 27934923
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
[TBL] [Abstract][Full Text] [Related]
20. U73122 affects the equilibria between the phosphoinositides as well as phospholipase C activity in unstimulated and thrombin-stimulated human and rabbit platelets.
Vickers JD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1156-63. PubMed ID: 8396627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
